Demethylating agent 5-aza-2'-deoxycytidine enhances susceptibility of bladder transitional cell carcinoma to Cisplatin.

Source:http://linkedlifedata.com/resource/pubmed/id/18538698

Download in:

View as

General Info

PMID
18538698